{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:03:27Z","timestamp":1769022207700,"version":"3.49.0"},"reference-count":46,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Health Extended Alliance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision Medicine\u2014acronimo HEAL ITALIA","award":["PE_00000019\u2014CUP D73C22001230006"],"award-info":[{"award-number":["PE_00000019\u2014CUP D73C22001230006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: This systematic review evaluates the effectiveness and safety of brachytherapy (BT), including low-dose-rate (LDR) and high-dose-rate (HDR) techniques, in the treatment of oral squamous cell carcinoma (OSCC). Methods: A systematic search was conducted in PubMed, Scopus, and Web of Science up to April 2025, according to PRISMA guidelines. The review was registered in PROSPERO (CRD42024581512). Eligible studies included cohort, case-control, and longitudinal studies in English investigating BT in OSCC patients. Risk of bias was assessed using ROBINS-I. Results: A total of 26 studies with 2286 patients were included where BT was employed as primary or adjuvant therapy, primarily for tumors of the tongue and floor of the mouth. Local control rates ranged from 72% to 95% for both LDR and HDR. HDR BT showed similar efficacy to LDR and offered logistical advantages. Acute and late toxicities included mucositis, soft tissue necrosis, and osteoradionecrosis, particularly with higher doses and large volumes. Combined BT and external beam radiotherapy (EBRT) improved outcomes in selected patients. Conclusions: BT remains an effective, organ-preserving option for early-stage OSCC. HDR BT is increasingly adopted due to its comparable efficacy and improved practicality. Optimal patient selection and precise dosimetric planning are crucial to minimize complications. Further prospective studies are warranted to define its role in modern multimodal treatment strategies.<\/jats:p>","DOI":"10.3390\/jcm14176033","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T14:43:18Z","timestamp":1756219398000},"page":"6033","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Brachytherapy in the Management of Oral Squamous Cell Carcinoma: A Systematic Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1820-899X","authenticated-orcid":false,"given":"Fariba","family":"Esperouz","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, 71122 Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4382-5074","authenticated-orcid":false,"given":"Mauro","family":"Lorusso","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, 71122 Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"De Lillo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, 71122 Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2153-0778","authenticated-orcid":false,"given":"Khrystyna","family":"Zhurakivska","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, 71122 Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4633-4893","authenticated-orcid":false,"given":"Lorenzo","family":"Lo Muzio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, 71122 Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3114-6048","authenticated-orcid":false,"given":"Domenico","family":"Ciavarella","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, 71122 Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6127-6105","authenticated-orcid":false,"given":"Lucio","family":"Lo Russo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, 71122 Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Esperouz, F., Ciavarella, D., Lorusso, M., Santarelli, A., Muzio, L.L., Campisi, G., and Russo, L.L. (2025). Critical review of OCT in clinical practice for the assessment of oral lesions. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1569197"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.4317\/medoral.18772","article-title":"Oral cancer: Current role of radiotherapy and chemotherapy","volume":"18","author":"Huang","year":"2013","journal-title":"Med. Oral Patol. Oral Y Cir. Bucal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"107104","DOI":"10.1016\/j.oraloncology.2024.107104","article-title":"Are we ready to use ultrasounds in the clinical assessment of depth of invasion and tumor thickness in oral squamous cell carcinoma? Results from a systematic review, meta-analysis and trial sequential analysis","volume":"159","author":"Esperouz","year":"2024","journal-title":"Oral Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5114\/jcb.2018.78995","article-title":"High-dose-rate interstitial brachytherapy in recurrent head and neck cancer: An effective salvage option","volume":"10","author":"Bhalavat","year":"2018","journal-title":"J. Contemp. Brachyther."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sankar, V., and Xu, Y. (2023). Oral Complications from Oropharyngeal Cancer Therapy. Cancers, 15.","DOI":"10.3390\/cancers15184548"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20201289","DOI":"10.1259\/bjr.20201289","article-title":"Volumetric modulated arc therapy (VMAT): A review of clinical outcomes-what is the clinical evidence for the most effective implementation?","volume":"95","author":"Hunte","year":"2022","journal-title":"Br. J. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2147\/CMAR.S351744","article-title":"Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment","volume":"14","author":"Koka","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"ref_9","unstructured":"Mayer, C., Gasalberti, D.P., and Kumar, A. (2025). Brachytherapy. StatPearls, StatPearls Publishing."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/030089161209800412","article-title":"High-dose-rate interstitial brachytherapy in early stage buccal mucosa and lip cancer: Report on 12 consecutive patients and review of the literature","volume":"98","author":"Vavassori","year":"2012","journal-title":"Tumori"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"20140146","DOI":"10.1259\/bjr.20140146","article-title":"Recent developments and best practice in brachytherapy treatment planning","volume":"87","author":"Lee","year":"2014","journal-title":"Br. J. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2009.01.005","article-title":"GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas","volume":"91","author":"Mazeron","year":"2009","journal-title":"Radiother. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e2021168S","DOI":"10.5826\/dpc.11S2a168S","article-title":"Radiotherapy in the Adjuvant and Advanced Setting of CSCC","volume":"11","author":"Muto","year":"2021","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0360-3016(00)00538-1","article-title":"Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins","volume":"48","author":"Lapeyre","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/PL00002416","article-title":"Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997","volume":"177","author":"Grabenbauer","year":"2001","journal-title":"Strahlenther. Onkol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00000421-200210000-00013","article-title":"Organ preservation with interstitial radiation for base of tongue cancer","volume":"25","author":"Barrett","year":"2002","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0360-3016(03)00507-8","article-title":"Effect of treatment time on outcome of radiotherapy for oral tongue carcinoma","volume":"57","author":"Hosokawa","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0360-3016(03)00597-2","article-title":"Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers","volume":"57","author":"Gibbs","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brachy.2004.09.002","article-title":"A comparison of treatments of squamous cell carcinoma of the base of tongue: Surgical resection combined with external radiation therapy, external radiation therapy alone, and external radiation therapy combined with interstitial radiation","volume":"3","author":"Barrett","year":"2004","journal-title":"Brachytherapy"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/hed.10377","article-title":"Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins","volume":"26","author":"Lapeyre","year":"2004","journal-title":"Head Neck"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/moe.2000.110087","article-title":"High-dose rate interstitial brachytherapy for stage I-II tongue cancer","volume":"90","author":"Umeda","year":"2000","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hed.20171","article-title":"Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base","volume":"27","author":"Norris","year":"2005","journal-title":"Head Neck"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijrobp.2005.02.002","article-title":"Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: Results in 44 patients","volume":"63","author":"Pommier","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/02841860500267881","article-title":"Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue","volume":"44","author":"Ihara","year":"2005","journal-title":"Acta Oncol."},{"key":"ref_25","first-page":"3933","article-title":"High-dose-rate interstitial brachytherapy for mobile tongue cancer: Influence of the non-irradiated period","volume":"26","author":"Kakimoto","year":"2006","journal-title":"Anticancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.radonc.2010.12.014","article-title":"Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lip","volume":"98","author":"Lock","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.rpor.2011.07.001","article-title":"Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer","volume":"16","author":"Petera","year":"2011","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11604-011-0005-z","article-title":"High dose rate brachytherapy using molds after chemoradiotherapy for oral cavity cancer","volume":"30","author":"Chatani","year":"2012","journal-title":"Jpn. J. Radiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ijrobp.2011.09.038","article-title":"High dose-rate versus low dose-rate brachytherapy for lip cancer","volume":"83","author":"Ghadjar","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hed.22981","article-title":"Interstitial brachytherapy for lower lip carcinoma: Global assessment in a retrospective study of 89 cases","volume":"35","author":"Rio","year":"2013","journal-title":"Head Neck"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.brachy.2014.02.443","article-title":"Iodine-125 brachytherapy in the management of squamous cell carcinoma of the oral cavity and oropharynx","volume":"13","author":"Stannard","year":"2014","journal-title":"Brachytherapy"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13014-014-0271-x","article-title":"Novel high dose rate lip brachytherapy technique to improve dose homogeneity and reduce toxicity by customized mold","volume":"9","author":"Feldman","year":"2014","journal-title":"Radiat. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/hed.23529","article-title":"Prognostic factors in squamous cell lip carcinoma treated with high-dose-rate brachytherapy","volume":"36","author":"Guinot","year":"2014","journal-title":"Head Neck"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brachy.2014.09.011","article-title":"Postoperative interstitial brachytherapy for resectable squamous cell carcinoma of the tongue","volume":"14","author":"Goineau","year":"2015","journal-title":"Brachytherapy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5114\/jcb.2017.69806","article-title":"Adjuvant high-dose-rate brachytherapy in the management of oral cavity cancers: 5 years of experience in Iran","volume":"9","author":"Kazemian","year":"2017","journal-title":"J. Contemp. Brachyther."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Jie, W.P., Bai, J.Y., and Li, B.B. (2018). Clinicopathologic Analysis of Oral Squamous Cell Carcinoma After (125)I Interstitial Brachytherapy. Technol. Cancer Res. Treat., 17.","DOI":"10.1177\/1533033818806906"},{"key":"ref_37","first-page":"e7910","article-title":"The Effect of High Dose Rate Interstitial Implant on Early and Locally Advanced Oral Cavity Cancers: Update and Long-Term Follow-Up Study","volume":"12","author":"Vedasoundaram","year":"2020","journal-title":"Cureus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00066-022-01901-w","article-title":"Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumours","volume":"198","author":"Ferenczi","year":"2022","journal-title":"Strahlenther. Onkol."},{"key":"ref_39","first-page":"100922","article-title":"Postoperative brachytherapy alone for 217 patients with early-stage oral cavity squamous cell carcinoma","volume":"51","author":"Schweizer","year":"2025","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bja.2019.08.015","article-title":"Use of the GRADE approach in systematic reviews and guidelines","volume":"123","author":"Granholm","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijom.2005.02.015","article-title":"A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue","volume":"34","author":"Umeda","year":"2005","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00066-023-02184-5","article-title":"Can interventional radiotherapy (brachytherapy) be an alternative to surgery in early-stage oral cavity cancer? A systematic review","volume":"200","author":"Draghini","year":"2024","journal-title":"Strahlenther. Onkol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"104626","DOI":"10.1016\/j.canrad.2025.104626","article-title":"Sole high dose-rate interstitial brachytherapy for early-stage tongue cancer: A systematic review","volume":"29","author":"Abdulkadir","year":"2025","journal-title":"Cancer Radiother."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Shi, J., Chen, J., He, G., and Peng, Q. (2025). Artificial intelligence in high-dose-rate brachytherapy treatment planning for cervical cancer: A review. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1507592"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20200842","DOI":"10.1259\/bjr.20200842","article-title":"Artificial intelligence in brachytherapy: A summary of recent developments","volume":"94","author":"Banerjee","year":"2021","journal-title":"Br. J. Radiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"102361","DOI":"10.1016\/j.ctrv.2022.102361","article-title":"Opportunities and challenges in combining immunotherapy and radiotherapy in head and neck cancers","volume":"105","author":"Wong","year":"2022","journal-title":"Cancer Treat. Rev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/6033\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:11Z","timestamp":1760034791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/6033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":46,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14176033"],"URL":"https:\/\/doi.org\/10.3390\/jcm14176033","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]}}}